U.S. markets open in 9 hours 30 minutes

ThermoGenesis Holdings, Inc. (THMO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.8054-0.0131 (-1.60%)
At close: 03:57PM EST
0.8500 +0.04 (+5.54%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close0.8185
Bid0.7800 x 1200
Ask0.8380 x 800
Day's Range0.7498 - 0.8500
52 Week Range0.3600 - 6.6700
Avg. Volume139,806
Market Cap2.526M
Beta (5Y Monthly)2.25
PE Ratio (TTM)N/A
EPS (TTM)-7.2200
Earnings DateMar 28, 2024 - Apr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for THMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ThermoGenesis Holdings, Inc.
    Analyst Report: Baxter International Inc.Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more